Dysbiotic microbiota interactions in Crohn's disease

Area of Science:

• Gastroenterology
• Microbiology
• Immunology

Background:

• Crohn's disease (CD) is a significant inflammatory bowel disease (IBD) marked by transmural inflammation.
• Altered gut microbial composition and reduced diversity are key features of CD pathogenesis.
• These microbial shifts compromise gut barrier function and trigger abnormal immune responses.

Purpose of the Study:

• To review modifications in the gut microbiota network during Crohn's disease progression.
• To examine how these microbial changes compromise gut barrier integrity and permit microbial translocation.
• To explore interactions between gut dysbiosis and CD pathophysiology, including genetic, immune, and lifestyle factors.

Main Methods:

• Literature review focusing on gut microbiota alterations in Crohn's disease.
• Analysis of studies investigating the impact of microbial dysbiosis on gut barrier function.
• Synthesis of research on the interplay between microbiota, host genetics, immune responses, and environmental factors in CD.

Main Results:

• Significant alterations in gut microbial composition and reduced diversity are consistently observed in CD patients.
• Gut dysbiosis contributes to compromised gut barrier integrity, facilitating microbial and product translocation.
• Microbiota dysbiosis interacts with host genetics, immune dysregulation, and fibrotic processes in CD.

Conclusions:

• Gut microbiota dysbiosis is central to Crohn's disease pathogenesis, affecting barrier function and immune responses.
• Understanding these complex interactions provides insights into disease mechanisms.
• Targeting the gut microbiota presents a promising therapeutic avenue for managing CD.